PET/MRI Outperforms Standard Imaging in Rectal Cancer Staging, Study Shows Written By Medha Baranwal17 Sept 2025 9:00 PM ISTPoland: A recent prospective study published in the International Journal of Colorectal Disease has revealed that using PET/MRI instead of...
Lupin bags USFDA approval for Multiple myeloma treatment Written By Ruchika Sharma17 Sept 2025 6:19 PM ISTMumbai: Global pharma major Lupin Limited has announced that the company has received approval from the United States Food and Drug Administration...
Merck gets USFDA Breakthrough Therapy Designation for Raludotatug deruxtecan for Platinum-Resistant Ovarian Cancer Written By Ruchika Sharma17 Sept 2025 1:03 PM ISTRahway: Merck, Daiichi Sankyo have announced that Raludotatug deruxtecan (R-DXd) has received Breakthrough Therapy Designation (BTD) from the U.S....
FDA Approves INLEXZO for BCG-Unresponsive Bladder Cancer Dr. Kamal Kant Kohli15 Sept 2025 8:30 PM ISTThe U.S. FDA has approved Johnson & Johnson's INLEXZO (gemcitabine intravesical system) for adults with BCG-unresponsive non-muscle invasive...
Preemptive Genetic Testing Feasible for Reducing Chemotherapy Toxicity in GI Cancer, Finds Trial Written By Medha Baranwal15 Sept 2025 8:00 PM ISTUSA: A prospective trial in gastrointestinal cancer patients found that preemptive DPYD/UGT1A1 genetic testing before chemotherapy was feasible,...
Biparametric MRI Effective as Multiparametric MRI in Detecting Prostate Cancer: Study Written By Jacinthlyn Sylvia14 Sept 2025 9:00 PM ISTA recent study published in the Journal of the American Medical Association found biparametric MRI to performs just as well as the current...
Millions of men could benefit from faster scan to diagnose prostate cancer: JAMA Dr. Kamal Kant Kohli12 Sept 2025 8:45 PM ISTA quicker, cheaper MRI scan was just as accurate at diagnosing prostate cancer as the current 30-40 minute scan and should be rolled out to make MRI...
SOX2: a key player in prostate cancer progression and treatment resistance: Study Dr. Kamal Kant Kohli11 Sept 2025 8:00 PM ISTProstate cancer remains a global health challenge, ranking as the second most common malignancy among men. While early-stage disease can be...
New blood test exhibits superior sensitivity in detecting HPV-associated head and neck cancers: Study Dr. Kamal Kant Kohli10 Sept 2025 8:45 PM ISTA new liquid biopsy blood test could help detect cases of human papillomavirus (HPV)-associated head and neck cancers with significantly higher...
Penile Implant Satisfaction Drops in Prostate Cancer Patients on Hormonal Treatment, reveals study Dr. Kamal Kant Kohli10 Sept 2025 8:45 PM ISTProstate cancer is the most common malignancy among men, with over 160,000 new cases diagnosed annually in the United States. Although advances in...
JnJ bags USFDA nod for bladder cancer treatment Inlexzo Written By Ruchika Sharma10 Sept 2025 11:46 AM ISTRaritan: Johnson & Johnson has received approval from the U.S. Food and Drug Administration (FDA) for INLEXZO (gemcitabine intravesical...
Are patients undergoing surgery for early-stage cancer at risk of persistent opioid use? Dr. Kamal Kant Kohli9 Sept 2025 10:00 PM ISTNew research indicates that many patients who undergo surgery with the intent to cure early-stage cancer continue or start opioid prescriptions in the...
